|Articles|July 1, 2000

Overactive Bladder: Examining the Burden of Disease
Volume 6
Issue 11 Suppl

Overactive Bladder: Special Considerations in the Geriatric Population

Author(s)Joseph G. Ouslander, MD, Ya-chen Tina Shih, PhD, James Malone-Lee, MD

Download PDF: Overactive Bladder: Special Considerations in the Geriatric Population

Articles in this issue

over 25 years ago

Article

Discussion

over 25 years ago

Article

Bibliography

over 25 years ago

Article

Participating Faculty

over 25 years ago

Article

Introduction: Overactive Bladder - Defining the Disease

over 25 years ago

Article

The Prevalence of Overactive Bladder

over 25 years ago

Article

Comorbidities Associated with Overactive Bladder

over 25 years ago

Article

Overactive Bladder Significantly Affects Overall Quality of Life

over 25 years ago

Article

Economic Considerations in Overactive Bladder

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Overactive Bladder: Special Considerations in the Geriatric Population

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

New Dermatologic Therapies Make Waves at Maui Derm 2026

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust